Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Oncology Reports|July 20, 2019
miR‑505 suppresses prostate cancer progression by targeting NRCAMXiao-Hui Ling, Hao Fu, Zhi-Yun Chen, et al.
Zhonghua Yi Xue Za Zhi|February 11, 2012
[Multicenter case-control study of the relationship between smoking and bladder cancer in China]Qi-Shan Dai, Hui-Chan He, Chao Cai, et al.
Pathology, Research and Practice|November 30, 2019
Increasing of FKBP9 can predict poor prognosis in patients with prostate cancerFu-Neng Jiang, Li-Jun Dai, Sheng-Bang Yang, et al.
Cancer Biology & Therapy|January 6, 2018
Expression of aromatase in tumor related stroma is associated with human bladder cancer progressionShulin Wu, Jianheng Ye, Zongwei Wang, et al.
World Journal of Gastroenterology|September 14, 2016
Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivoQi Xie, Min-Yi Wu, Ding-Xuan Zhang, et al.
Pathology Oncology Research : POR|March 5, 2013
MicroRNA-335 acts as a candidate tumor suppressor in prostate cancerSi-wei Xiong, Tian-xin Lin, Ke-wei Xu, et al.
Molecular Medicine Reports|July 6, 2017
miR‑30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoproteinYa-Qiang Huang, Xiao-Hui Ling, Run-Qiang Yuan, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 2, 2011
Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomyXue-Cheng Bi, Jiu-Min Liu, Xiang-Guang Zheng, et al.
Pageof 11